-
Je něco špatně v tomto záznamu ?
Comparison of HepaRG and HepG2 cell lines to model mitochondrial respiratory adaptations in non‐alcoholic fatty liver disease
TE. Maseko, M. Elkalaf, E. Peterová, H. Lotková, P. Staňková, J. Melek, J. Dušek, P. Žádníková, D. Čížková, A. Bezrouk, P. Pávek, Z. Červinková, O. Kučera
Jazyk angličtina Země Řecko
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2006 do Před 1 rokem
Freely Accessible Science Journals
od 2006
ProQuest Central
od 2012-01-01
Medline Complete (EBSCOhost)
od 2013-08-01
Health & Medicine (ProQuest)
od 2012-01-01
PubMed
38186319
DOI
10.3892/ijmm.2023.5342
Knihovny.cz E-zdroje
- MeSH
- buněčné linie MeSH
- buňky Hep G2 MeSH
- dýchání MeSH
- kyseliny mastné neesterifikované MeSH
- lidé MeSH
- mitochondrie MeSH
- nealkoholová steatóza jater * MeSH
- triglyceridy MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Although some clinical studies have reported increased mitochondrial respiration in patients with fatty liver and early non‐alcoholic steatohepatitis (NASH), there is a lack of in vitro models of non‐alcoholic fatty liver disease (NAFLD) with similar findings. Despite being the most commonly used immortalized cell line for in vitro models of NAFLD, HepG2 cells exposed to free fatty acids (FFAs) exhibit a decreased mitochondrial respiration. On the other hand, the use of HepaRG cells to study mitochondrial respiratory changes following exposure to FFAs has not yet been fully explored. Therefore, the present study aimed to assess cellular energy metabolism, particularly mitochondrial respiration, and lipotoxicity in FFA‐treated HepaRG and HepG2 cells. HepaRG and HepG2 cells were exposed to FFAs, followed by comparative analyses that examained cellular metabolism, mitochondrial respiratory enzyme activities, mitochondrial morphology, lipotoxicity, the mRNA expression of selected genes and triacylglycerol (TAG) accumulation. FFAs stimulated mitochondrial respiration and glycolysis in HepaRG cells, but not in HepG2 cells. Stimulated complex I, II‐driven respiration and β‐oxidation were linked to increased complex I and II activities in FFA‐treated HepaRG cells, but not in FFA‐treated HepG2 cells. Exposure to FFAs disrupted mitochondrial morphology in both HepaRG and HepG2 cells. Lipotoxicity was induced to a greater extent in FFA‐treated HepaRG cells than in FFA‐treated HepG2 cells. TAG accumulation was less prominent in HepaRG cells than in HepG2 cells. On the whole, the present study demonstrates that stimulated mitochondrial respiration is associated with lipotoxicity in FFA‐treated HepaRG cells, but not in FFA‐treated HepG2 cells. These findings suggest that HepaRG cells are more suitable for assessing mitochondrial respiratory adaptations in the developed in vitro model of early‐stage NASH.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007303
- 003
- CZ-PrNML
- 005
- 20240612111916.0
- 007
- ta
- 008
- 240412s2024 gr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3892/ijmm.2023.5342 $2 doi
- 035 __
- $a (PubMed)38186319
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Maseko, Tumisang Edward $u Department of Physiology, Charles University, Faculty of Medicine in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 245 10
- $a Comparison of HepaRG and HepG2 cell lines to model mitochondrial respiratory adaptations in non‐alcoholic fatty liver disease / $c TE. Maseko, M. Elkalaf, E. Peterová, H. Lotková, P. Staňková, J. Melek, J. Dušek, P. Žádníková, D. Čížková, A. Bezrouk, P. Pávek, Z. Červinková, O. Kučera
- 520 9_
- $a Although some clinical studies have reported increased mitochondrial respiration in patients with fatty liver and early non‐alcoholic steatohepatitis (NASH), there is a lack of in vitro models of non‐alcoholic fatty liver disease (NAFLD) with similar findings. Despite being the most commonly used immortalized cell line for in vitro models of NAFLD, HepG2 cells exposed to free fatty acids (FFAs) exhibit a decreased mitochondrial respiration. On the other hand, the use of HepaRG cells to study mitochondrial respiratory changes following exposure to FFAs has not yet been fully explored. Therefore, the present study aimed to assess cellular energy metabolism, particularly mitochondrial respiration, and lipotoxicity in FFA‐treated HepaRG and HepG2 cells. HepaRG and HepG2 cells were exposed to FFAs, followed by comparative analyses that examained cellular metabolism, mitochondrial respiratory enzyme activities, mitochondrial morphology, lipotoxicity, the mRNA expression of selected genes and triacylglycerol (TAG) accumulation. FFAs stimulated mitochondrial respiration and glycolysis in HepaRG cells, but not in HepG2 cells. Stimulated complex I, II‐driven respiration and β‐oxidation were linked to increased complex I and II activities in FFA‐treated HepaRG cells, but not in FFA‐treated HepG2 cells. Exposure to FFAs disrupted mitochondrial morphology in both HepaRG and HepG2 cells. Lipotoxicity was induced to a greater extent in FFA‐treated HepaRG cells than in FFA‐treated HepG2 cells. TAG accumulation was less prominent in HepaRG cells than in HepG2 cells. On the whole, the present study demonstrates that stimulated mitochondrial respiration is associated with lipotoxicity in FFA‐treated HepaRG cells, but not in FFA‐treated HepG2 cells. These findings suggest that HepaRG cells are more suitable for assessing mitochondrial respiratory adaptations in the developed in vitro model of early‐stage NASH.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nealkoholová steatóza jater $7 D065626
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a mitochondrie $7 D008928
- 650 _2
- $a dýchání $7 D012119
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a kyseliny mastné neesterifikované $7 D005230
- 650 _2
- $a triglyceridy $7 D014280
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Elkalaf, Moustafa $u Department of Physiology, Charles University, Faculty of Medicine in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Peterová, Eva $u Department of Physiology, Charles University, Faculty of Medicine in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Lotková, Halka $u Department of Physiology, Charles University, Faculty of Medicine in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Staňková, Pavla $u Department of Physiology, Charles University, Faculty of Medicine in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Melek, Jan $u Department of Physiology, Charles University, Faculty of Medicine in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Dušek, Jan $u Department of Physiology, Charles University, Faculty of Medicine in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic $7 xx0318365
- 700 1_
- $a Žádníková, Petra $u Department of Physiology, Charles University, Faculty of Medicine in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Čížková, Dana $u Department of Histology and Embryology, Charles University, Faculty of Medicine in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Bezrouk, Aleš $u Department of Medical Biophysics, Charles University, Faculty of Medicine in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Pávek, Petr $u Department of Pharmacology and Toxicology, Charles University, Faculty of Pharmacy in Hradec Kralove, 500 05 Hradec Kralove, Czech Republic
- 700 1_
- $a Červinková, Zuzana $u Department of Physiology, Charles University, Faculty of Medicine in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Kučera, Otto $u Department of Physiology, Charles University, Faculty of Medicine in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 773 0_
- $w MED00173213 $t International journal of molecular medicine $x 1791-244X $g Roč. 53, č. 2 (2024)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38186319 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240612111917 $b ABA008
- 999 __
- $a ok $b bmc $g 2081344 $s 1217070
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 53 $c 2 $e 20240108 $i 1791-244X $m International journal of molecular medicine $n Int. J. Mol. Med. $x MED00173213
- LZP __
- $a Pubmed-20240412